Your session is about to expire
← Back to Search
Nurse-led Intervention for Families of Critically Ill Patients (SET-to-Meet Trial)
N/A
Waitlist Available
Led By Jennifer B Seaman, PhD,RN,CHPN
Research Sponsored by University of Pittsburgh
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up throughout the 3 month pilot phase
Awards & highlights
SET-to-Meet Trial Summary
This trial is testing a new way to ensure that families of critically ill patients are regularly updated on their loved one's condition through interdisciplinary meetings.
Who is the study for?
This trial is for clinicians (nurses, care managers, social workers, physicians) working at the pilot site and patients aged 18 or older who are admitted to the ICU for intensive care services at one of the three pilot sites during the testing phase.Check my eligibility
What is being tested?
The SET-to-Meet intervention is being tested. It's a nurse-led strategy aiming to improve routine interdisciplinary family meetings in ICUs according to best practice guidelines. The study will assess how feasible and acceptable this approach is.See study design
What are the potential side effects?
Since SET-to-Meet is a procedural intervention focused on improving communication and adherence to guidelines rather than a medical treatment, it does not have traditional side effects like drugs do.
SET-to-Meet Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ throughout the 3 month pilot phase
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~throughout the 3 month pilot phase
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Acceptability of the intervention to clinicians assessed via focus groups
Adherence to elements of intervention protocol
Clinician Satisfaction with the intervention assessed via on-line survey
+2 moreSecondary outcome measures
Proportion of patients with a family meeting
Time elapsed until the first family meeting
SET-to-Meet Trial Design
1Treatment groups
Experimental Treatment
Group I: SET-to-MEETExperimental Treatment1 Intervention
This is a single arm, open trial that will be conducted in parallel in 3 separate ICUs. Each site will receive the SET-to-MEET intervention.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
SET-to-Meet
2019
N/A
~100
Find a Location
Who is running the clinical trial?
Cambia Health FoundationOTHER
3 Previous Clinical Trials
126 Total Patients Enrolled
University of PittsburghLead Sponsor
1,719 Previous Clinical Trials
16,342,244 Total Patients Enrolled
13 Trials studying Critical Illness
7,773 Patients Enrolled for Critical Illness
Jennifer B Seaman, PhD,RN,CHPNPrincipal InvestigatorUniversity of Pittsburgh School of Nursing
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- Only healthcare providers who work or provide services at the pilot site can participate.You are at least 18 years old and have been admitted to the intensive care unit (ICU) at one of the three selected hospitals during the pilot testing phase.
Research Study Groups:
This trial has the following groups:- Group 1: SET-to-MEET
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are participants still being accepted into this investigation?
"According to clinicaltrials.gov, this medication trial is not presently enrolling participants; the study was initially posted on June 13th 2019 and most recently updated October 31st 2022. Despite no longer recruiting individuals, there are 169 other ongoing trials requiring volunteers at the moment."
Answered by AI
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger